Functional Analysis of Dual-Specificity Protein Phosphatases in Angiogenesis

Mathieu Amand1, Charlotte Erpicum2, Christine Gilles2

  • 1Immunology and Infectious Diseases Unit, GIGA-Signal Transduction, University of Liège, 1, Avenue de l'hôpital, B34., 4000, Liège, Belgium.

Insights

Dual-specificity phosphatases (DSPs) regulate angiogenesis. This study details methods to investigate the role of DUSP3, an atypical DSP, in endothelial cells and angiogenesis, validating findings in knockout mice.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Angiogenesis is crucial for cancer progression and a therapeutic target.
  • Dual-specificity phosphatases (DSPs) regulate endothelial cell functions vital for angiogenesis.
  • DUSP3 is an atypical DSP recently identified as a key player in angiogenesis.

Purpose of the Study:

  • To provide detailed protocols and models for investigating DUSP3's role in endothelial cells and angiogenesis.
  • To establish methods for DUSP3 depletion and functional assays in angiogenesis.

Main Methods:

  • Small interfering RNA (siRNA)-mediated DUSP3 depletion in human umbilical vein endothelial cells (HUVECs).
  • In vitro angiogenesis assays: tube formation, proliferation, and spheroid sprouting.
  • In vivo angiogenesis models: Matrigel plug assay, Lewis lung carcinoma xenograft, and ex vivo aortic ring assay in DUSP3-knockout mice.

Main Results:

  • Established efficient siRNA protocols for DUSP3 knockdown in HUVECs.
  • Demonstrated DUSP3's involvement in endothelial cell migration, proliferation, and tube formation.
  • Validated DUSP3's critical role in angiogenesis in vivo using knockout mouse models.

Conclusions:

  • DUSP3 is a significant regulator of angiogenesis and endothelial cell function.
  • The presented protocols and models are valuable for studying DUSP3 and other phosphatases in angiogenesis.
  • DUSP3 represents a potential therapeutic target for anti-angiogenic cancer therapies.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.4K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.0K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.7K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K